U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C81H113N21O25S3
Molecular Weight 1877.085
Optical Activity UNSPECIFIED
Defined Stereocenters 12 / 12
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of EC-0305

SMILES

CCCC(=O)OCN([C@H](C[C@@H](OC(C)=O)C1=NC(=CS1)C(=O)N[C@H](C[C@H](C)C(=O)NNC(=O)OCCSSC[C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(O)=O)NC(=O)CC[C@H](NC(=O)C2=CC=C(NCC3=NC4=C(N=C3)N=C(N)NC4=O)C=C2)C(O)=O)C(O)=O)CC5=CC=C(O)C=C5)C(C)C)C(=O)[C@@H](NC(=O)[C@H]6CCCCN6C)[C@@H](C)CC

InChI

InChIKey=CDSJGIIWNPXYAR-QURSGCAYSA-N
InChI=1S/C81H113N21O25S3/c1-9-14-63(110)126-40-102(76(119)64(42(5)10-2)96-73(117)57-16-11-12-28-101(57)8)58(41(3)4)35-59(127-44(7)103)75-95-55(38-128-75)72(116)89-48(32-45-17-23-50(104)24-18-45)31-43(6)67(111)99-100-81(124)125-29-30-129-130-39-56(78(122)123)94-71(115)54(34-62(108)109)93-69(113)51(15-13-27-85-79(82)83)91-70(114)53(33-61(106)107)90-60(105)26-25-52(77(120)121)92-68(112)46-19-21-47(22-20-46)86-36-49-37-87-66-65(88-49)74(118)98-80(84)97-66/h17-24,37-38,41-43,48,51-54,56-59,64,86,104H,9-16,25-36,39-40H2,1-8H3,(H,89,116)(H,90,105)(H,91,114)(H,92,112)(H,93,113)(H,94,115)(H,96,117)(H,99,111)(H,100,124)(H,106,107)(H,108,109)(H,120,121)(H,122,123)(H4,82,83,85)(H3,84,87,97,98,118)/t42-,43-,48+,51-,52-,53-,54-,56-,57+,58+,59+,64-/m0/s1

HIDE SMILES / InChI

Molecular Formula C81H113N21O25S3
Molecular Weight 1877.085
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 12 / 12
E/Z Centers 4
Optical Activity UNSPECIFIED

Approval Year

Substance Class Chemical
Created
by admin
on Sat Dec 16 11:41:00 GMT 2023
Edited
by admin
on Sat Dec 16 11:41:00 GMT 2023
Record UNII
XBG8SF1OJB
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
EC-0305
Common Name English
EC 0305
Code English
F-0305
Code English
L-ALANINE, N-(4-(((2-AMINO-3,4-DIHYDRO-4-OXO-6-PTERIDINYL)METHYL)AMINO)BENZOYL)-L-.GAMMA.-GLUTAMYL-L-.ALPHA.-ASPARTYL-L-ARGINYL-L-.ALPHA.-ASPARTYL-3-((2-(((2-((2S,4R)-4-(((2-((1R,3R)-1-(ACETYLOXY)-4-METHYL-3-(((2S,3S)-3-METHYL-2-((((2R)-1-METHYL-2-PIPERI
Systematic Name English
Code System Code Type Description
MANUFACTURER PRODUCT INFORMATION
EC-0305
Created by admin on Sat Dec 16 11:41:00 GMT 2023 , Edited by admin on Sat Dec 16 11:41:00 GMT 2023
PRIMARY F0305 - Anti-FANCD2 antibody produced in rabbit
PUBCHEM
24773035
Created by admin on Sat Dec 16 11:41:00 GMT 2023 , Edited by admin on Sat Dec 16 11:41:00 GMT 2023
PRIMARY
CAS
1059477-97-2
Created by admin on Sat Dec 16 11:41:00 GMT 2023 , Edited by admin on Sat Dec 16 11:41:00 GMT 2023
PRIMARY
FDA UNII
XBG8SF1OJB
Created by admin on Sat Dec 16 11:41:00 GMT 2023 , Edited by admin on Sat Dec 16 11:41:00 GMT 2023
PRIMARY
Related Record Type Details
ACTIVE MOIETY
When tested against more chemoresistant folate receptor expressing M109 and 4T1-cl2 tumors, EC0305 displayed superior antitumor activity over a previously disclosed folate conjugate of desacetylvinblastine monohydrazide (EC145). These studies demonstrate that EC0305 has significant antiproliferative activity against FR expressing tumors, including those which are generally more chemoresistant, and that EC0305 should be considered for development as a candidate for the treatment of advanced FR-expressing human cancers.